Question 1

Is STRYKE Foundation for Rare Disease Research and Treatment a tax-exempt 501(c)(3)?

Accepted Answer

Yes — STRYKE Foundation for Rare Disease Research and Treatment is recognised by the IRS as a 501(c)(3) organisation (EIN 93-1503591). The IRS recognised STRYKE Foundation for Rare Disease Research and Treatment as tax-exempt in February 2024.

Question 2

What is STRYKE Foundation for Rare Disease Research and Treatment's EIN?

Accepted Answer

STRYKE Foundation for Rare Disease Research and Treatment

Q: When was STRYKE Foundation for Rare Disease Research and Treatment founded or recognised by the IRS?

STRYKE Foundation for Rare Disease Research and Treatment was recognised by the IRS as a tax-exempt organisation in February 2024. The IRS ruling date is the earliest authoritative date available for most US nonprofits.

DBA: N/A

Other name: The Styrke Foundation for Rare Disease

EIN: 93-1503591

IRS ActivePublic Charity501(c)(3)Philanthropy & GrantmakingNorwalk, CTRuling: February 2024

Question 3

What does STRYKE Foundation for Rare Disease Research and Treatment do?

Accepted Answer

Will engage in charitable activities that support and develop therapeutic treatments and/or cures that will improve lives and transform the health of individuals living with orphan diseases.

Question 4

Where is STRYKE Foundation for Rare Disease Research and Treatment located?

Accepted Answer

STRYKE Foundation for Rare Disease Research and Treatment is located at 26 Point Road, Norwalk, CT, 06854.

Question 5

When was STRYKE Foundation for Rare Disease Research and Treatment founded or recognised by the IRS?

Accepted Answer

STRYKE Foundation for Rare Disease Research and Treatment

DBA: N/A

Other name: The Styrke Foundation for Rare Disease

EIN: 93-1503591

IRS ActivePublic Charity501(c)(3)Philanthropy & GrantmakingNorwalk, CTRuling: February 2024

Question 6

What is STRYKE Foundation for Rare Disease Research and Treatment's annual revenue?

Accepted Answer

On its most recent Form 990 (fiscal year 2024), STRYKE Foundation for Rare Disease Research and Treatment reported $1.8M in total revenue and $51K in total expenses.

Question 7

Has STRYKE Foundation for Rare Disease Research and Treatment been auto-revoked by the IRS?

Accepted Answer

No — STRYKE Foundation for Rare Disease Research and Treatment (EIN 93-1503591) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.

Question 8

Is STRYKE Foundation for Rare Disease Research and Treatment listed in IRS Publication 78?

Accepted Answer

Yes — STRYKE Foundation for Rare Disease Research and Treatment is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.

Loading profile…

STRYKE Foundation for Rare Disease Research and Treatment

Due Diligence Summary

AI Organization Overview

Mission Statement

Organization Details

Contact

Financial Snapshot

Location

Governance

Frequently asked questions about STRYKE Foundation for Rare Disease Research and Treatment